Key result
IBD is linked to increased arterial stiffness surpassing well-controlled hypertension in older patients.
Why the study?
Chronic inflammatory diseases are related to earlier onset of atherosclerosis, but arterial stiffness in inflammatory bowel disease patients without hypertension or diabetes compared to well-controlled hypertension patients was unclear.
Does inflammatory bowel disease increase arterial stiffness similarly to well-controlled hypertension?
Observational (n=162)
Does inflammatory bowel disease increase arterial stiffness similarly to well-controlled hypertension?
Inflammatory bowel disease is associated with increased arterial stiffness comparable to or exceeding that of well-controlled hypertension, suggesting IBD duration is a risk factor for subclinical organ damage.
Answers are grounded in this paper and cite their sources.
Arterial stiffness may warrant monitoring in IBD; leaves open its independence from hypertension as a vascular risk marker.
PURPOSE: Chronic inflammatory diseases are related with earlier onset of atherosclerosis. We hypothesized that inflammatory bowel disease patients with chronic, systemic inflammation have an increased arterial stiffness associated with the disease duration. Also, we wanted to compare arterial stiffness markers between inflammatory bowel disease and well-controlled hypertension patients. MATERIALS AND METHODS: A total of 89 inflammatory bowel disease patients (60 patients with Crohn's disease and 29 patients with ulcerative colitis, age range 20-64 years) without history of arterial hypertension or diabetes were enrolled and age matched with a control group of patients (73 patients, age range 25-69 years, 41 (56.1%) males) with known history of well-controlled arterial hypertension. We have used a noninvasive device that simultaneously measures brachial blood pressure and estimates PWV and AIx in inflammatory bowel disease and hypertension groups of patients. RESULTS: Patients with pathological PWV values were significantly older, had significantly longer duration of inflammatory bowel disease, higher values of serum cholesterol and HDL-cholesterol, and higher AIx (17.4% vs. 9.8%) (all p < .05). Higher PWV was associated with age and duration of inflammatory bowel disease in the linear regression model. PWV values were higher in hypertensive patients in the first two age quartiles while interestingly, in the last two quartiles, PWV was lower than in inflammatory bowel disease group of patients. CONCLUSIONS: Chronic subclinical inflammation is responsible for dyslipidemia and accelerated atherosclerosis which consequently alterates arterial elasticity. Inflammatory bowel disease and its duration should also be considered a risk factor for subclinical organ damage, as well as hypertension.
No takes yet. Share an insight, caveat, or question.
Prijić et al. (2018) conducted an observational in Inflammatory bowel disease (n=162). Inflammatory bowel disease vs. Well-controlled arterial hypertension was evaluated on Pulse wave velocity (PWV) and augmentation index (AIx). Inflammatory bowel disease was associated with increased arterial stiffness, with pulse wave velocity values surpassing those of well-controlled hypertensive patients in older age quartiles.
Synapse has enriched 10 related papers. Consider them for comparative context: